Product Information
METHYLPHENIDATE ER(LA) 30 MG CP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $2.0275 per EA under NDC 00093534701. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jul 13, 2012.
Strength
30 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093534701
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079031FDA Approved
7/13/2012
On Market Since
7/16/2012
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 53.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0275 per EA |
|---|---|
| All-time high | $5.0876 (Sep 14, 2016) |
| All-time low | $1.0799 (May 19, 2021) |
| 52-week high | $2.9073 |
| 52-week low | $2.0275 |
| Median price | $3.3370 |
| Average price | $3.1219 |
| Largest weekly change | +71.5% (Aug 23, 2023) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER(LA) 30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER(LA) 30 MG CP, manufactured by Teva Pharmaceuticals USA Inc., is $2.0275 per EA (NDC 00093534701), effective Aug 19, 2026.
How has the price of METHYLPHENIDATE ER(LA) 30 MG CP changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has declined 53.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER(LA) 30 MG CP?
Since Nov 28, 2013, the NADAC for METHYLPHENIDATE ER(LA) 30 MG CP has ranged from a low of $1.0799 (May 19, 2021) to a high of $5.0876 (Sep 14, 2016), with a median of $3.3370 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER(LA) 30 MG CP?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE ER(CD) 30 MG CP, is $1.8984 per EA — about 6% below METHYLPHENIDATE ER(LA) 30 MG CP.
Who manufactures METHYLPHENIDATE ER(LA) 30 MG CP?
METHYLPHENIDATE ER(LA) 30 MG CP (NDC 00093534701) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.